Company / Capital Expenditures
Crinetics Pharmaceuticals, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$5.8M
FY2025
5-year range
$436.0K / $5.8M
FY2021-FY2025
Trend
+49.9%
vs FY2024
Sector context
#71 of 194
Health Care
What the data says
At $6M, Crinetics Pharmaceuticals, Inc.'s capital expenditures ranks #71 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $190,000 in FY2018 to $6M in FY2025.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of +40.3%.
Improved from $5M to $6M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +51.5%
- 5-Year CAGR
- +40.3%
- 10-Year CAGR
- -
Sector benchmark
#71 of 194 in Health CareTop 37% of 194This company $5.8M Sector average $117.5M
▼
-95.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 49.9% year-over-year.
- Ranks #71 out of 194 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8M | +49.9% |
| FY2024 | $3.8M | -18.0% |
| FY2023 | $4.7M | +183.1% |
| FY2022 | $1.7M | +279.8% |
| FY2021 | $436.0K | -58.8% |
| FY2020 | $1.1M | +248.4% |
| FY2019 | $304.0K | +60.0% |
| FY2018 | $190.0K | -37.5% |
| FY2017 | $304.0K | +60.0% |
| FY2016 | $190.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026